Institutional investors purchased a net $137.1 thousand shares of REGN during the quarter ended December 2017. This may signal that the smart money is gaining interest in this company as the 68.76% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
ADAMCAPITAL GESTÃO DE RECURSOS L... Bought 72.3 Thousand shares of Regeneron Pharmaceuticals...
JENNISON ASSOCIATES LLC Bought 13.0 Thousand shares of Regeneron Pharmaceuticals...